Mortality in COPD: Comparison of Different Predictors in Patients Seeking a Pulmonary Rehabilitation Program

Autores

  • Thamyres Spositon da Silva Unopar, Stricto Sensu Graduate Program in Rehabilitation Sciences. PR Brazil.
  • Antenor Rodrigues State University of Londrina, Department of Physical Therapy, Research Laboratory in Pulmonary Physical Therapy. PR Brazil.
  • Juliiana Fonseca Micheleti State University of Londrina, Department of Physical Therapy, Research Laboratory in Pulmonary Physical Therapy. PR Brazil.
  • Nidia Aparecida Hernandes State University of Londrina, Stricto Sensu Graduate Program in Rehabilitation Sciences. PR Brazil.
  • Fabio Pitta State University of Londrina, Stricto Sensu Graduate Program in Rehabilitation Sciences. PR Brazil.
  • Karina Couto Furlanetto Unopar, Stricto Sensu Graduate Program in Rehabilitation Sciences. PR Brazil.

DOI:

https://doi.org/10.17921/2447-8938.2019v21n4p390-6

Resumo

Resumo

É clinicamente relevante identificar fatores preditores de mortalidade isolados ou multidimensionais em pacientes com Doença Pulmonar Obstrutiva Crônica (DPOC). O objetivo desse esuto foi comparar diferentes fatores na identificação de pacientes classificados em alto risco de morte e identificar o valor prognóstico de fatores isolados frente ao índice BODE. Foram avaliados pacientes quanto a fatores associado a mortalidade: função pulmonar com a medida do volume expiratório forçado (VEF1); índice de massa corpórea (IMC); índice de massa magra corporal (IMMC); Incremental Shuttle Walk Test (ISWT) com a estimativa do consumo máximo de oxigênio (VO2máx); teste de caminhada de seis minutos (TC6min); escala Medical Research Council; índice BODE e tempo sedentário. Pontos de corte previamente associados com mortalidade foram utilizados para calcular a proporção de pacientes em alto risco. Análise de curva ROC foi utilizada para testar o valor prognóstico das variáveis isoladas frente ao BODE. Foram incluídos 162 pacientes (86 homens, idade 67±8 anos). As proporções de pacientes classificados em alto risco variaram de 12,6% até 76,5% de acordo com os oito fatores analisados (P<0,05 vs todos). A área sob a curva (AUC) desses fatores testados isoladamente frente ao índice BODE indicou insatisfatória capacidade discriminativa (0,26 < AUC < 0,44). Existe uma variabilidade expressiva na proporção dos pacientes classificados como “alto risco” de acordo com cada fator preditor de mortalidade. Além disso, a avaliação prognóstica do paciente obtida com o índice BODE não pode ser substituída pela avaliação de um único fator preditor.

 

Palavras-chave: Doença Pulmonar Obstrutiva Crônica. Mortalidade. Exercício.

 

Abstract

It is clinically relevant to identify isolated factors or multidimensional predictors of mortality in patients with Chronic Obstructive Pulmonary Disease (COPD). To compare different factors in the identification of patients classified as high risk of death and to identify the prognostic value of isolated factors against the BODE index. Patients were evaluated considering the factors associated with mortality: pulmonary function with forced expiratory volume (FEV1); body mass index (BMI); body mass index (LMWI); Incremental Shuttle Walk Test (ISWT) with estimation of maximal oxygen consumption (VO2max); six-minute walk test (6MWT); Medical Research Council scale; BODE index and sedentary time. Cut-off points previously associated with risk of death were used to calculate the proportion of patients at high risk of death. ROC curve analysis was used to test the prognostic value of each variable against the BODE index. A total of 162 patients (86 men, age 67 ± 8 years) were included. The proportions of patients classified as high risk ranged from 12.6 to 76.5% according to all eight factors analyzed (P <0.05 vs all). The area under the curve (AUC) of each factor analyzed against the BODE index indicated insufficient discriminative capacity (0.26 < AUC < 0.44). Conclusion: There is an expressive variability of patients classified as "high risk" according to each predictor factor. Moreover, the prognostic evaluation of the patient using the BODE index cannot be replaced by the assessment of a single predictive factor.

 

Keywords: Chronic Obstructive Pulmonary Disease, Mortality, Exercise.

Biografia do Autor

Karina Couto Furlanetto, Unopar, Stricto Sensu Graduate Program in Rehabilitation Sciences. PR Brazil.

Departamento de Fisioterapia da UNOPAR. Área de interesse: Fisioterapia Respiratória. Docente do programa de mestrado em ciências da reabilitação associado UEL-UNOPAR.

Referências

Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease (GOLD). Updated 2018. [acessed out 10, 2018]. Available from http://goldcopd.org/.

Spruit MA, Singh SJ, Garvey C, ZuWallack R, Nici L, Rochester C, et al. American Thoracic Society/European Respiratory Society statement on pulmonary rehabilitation. Am J Respir Crit Care Med 2013;188(8):e13-64. 0.1164/rccm.200508-1211ST

O'Donnell DE, Bertley JC, Chau LK, Webb KA. Qualitative aspects of exertional breathlessness in chronic airflow limitation: pathophysiologic mechanisms. Am J Respir Crit Care Med 1997;155(1):109-15.

Casanova C, Marin JM, Martinez-Gonzalez C, de Lucas-Ramos P, Mir-Viladrich I, Cosio B, et al. Differential Effect of Modified Medical Research Council Dyspnea, COPD Assessment Test, and Clinical COPD Questionnaire for Symptoms Evaluation Within the New GOLD Staging and Mortality in COPD. Chest 2015;148(1):159-68. doi: 10.1378/chest.14-2449.

Vestbo J, Prescott E, Almdal T, Dahl M, Nordestgaard BG, Andersen T, et al. Body mass, fat-free body mass, and prognosis in patients with chronic obstructive pulmonary disease from a random population sample: findings from the Copenhagen City Heart Study. Am J Respir Crit Care Med 2006;173(1):79-83.

Landbo C, Prescott E, Lange P, Vestbo J, Almdal TP. Prognostic value of nutritional status in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999;160(6):1856-61.

Cote CG, Pinto-Plata V, Kasprzyk K, Dordelly LJ, Celli BR. The 6-min walk distance, peak oxygen uptake, and mortality in COPD. Chest 2007;132(6):1778-1785.

Furlanetto KC, Donaria L, Schneider LP, Lopes JR, Ribeiro M, Fernandes KB, et al. Sedentary behavior is an independent predictor of mortality in subjects with COPD. Respir Care 2017;62(5):579-88. doi: 10.4187/respcare.05306.

Celli BR, Cote CG, Marin JM, Casanova C, Montes DO, Mendez RA, et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med 2004;350(10):1005-1012.

Chronic respiratory diseases. COPD predicted to be third leading cause of death in 2030. World Health Organization. [accessed out 18, 2018]. Available from: http://www.who.int/respiratory/copd/burden/en/.

Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, et al. Standardisation of spirometry. Eur Respir J 2005;26(2):319-338.

Pereira C, Sato T, Rodrigues S. Novos valores de referência para espirometria forçada em brasileiros da raça branca. J Bras Pneumol 2007;33(4):397-406.

Price KL, Earthman CP. Update on body composition tools in clinical settings: computed tomography, ultrasound, and bioimpedance applications for assessment and monitoring. Eur J Clin Nutr 2019;73(2):187-93. doi: 10.1038/s41430-018-0360-2.

Holland AE, Spruit MA, Troosters T, Puhan MA, Pepin V, Saey D, et al. An official European Respiratory Society/American Thoracic Society technical standard: field walking tests in chronic respiratory disease. Eur Respir J 2014;44(6):1428-46. doi: 10.1183/09031936.00150314

Britto RR, Probst VS, de Andrade AF, Samora GA, Hernandes NA, Marinho PE, et al. Reference equations for the six-minute walk distance based on a Brazilian multicenter study. Braz J Phys Ther 2013;17(6):556-563.

Singh SJ, Morgan MD, Scott S, Walters D, Hardman AE. Development of a shuttle walking test of disability in patients with chronic airways obstruction. Thorax 1992;47(12):1019-1024.

Probst VS, Hernandes NA, Teixeira DC, Felcar JM, Mesquita RB, Goncalves CG, et al. Reference values for the incremental shuttle walking test. Resp Med 2012;106(2):243-248.

Kovelis D, Segretti NO, Probst VS, Lareau SC, Brunetto AF, Pitta F. Validation of the Modified Pulmonary Functional Status and Dyspnea Questionnaire and the Medical Research Council scale for use in Brazilian patients with chronic obstructive pulmonary disease. J Bras Pneumol 2008;34(12):1008-1018.

Cavalheri V, Donaria L, Ferreira T, Finatti M, Camillo CA, Cipulo Ramos EM, et al. Energy expenditure during daily activities as measured by two motion sensors in patients with COPD. Respir Med 2011;105(6):922-929.

Gore S, Blackwood J, Guyette M, Alsalaheen B. Validity and reliability of accelerometers in patients with COPD: a systematic review. J Cardiopulm Rehabil Prev 2018;38(3):147-58. doi: 10.1097/HCR.0000000000000284.

Demeyer H, Burtin C, Van Remoortel H, Hornikx M, Langer D, Decramer M, et al. Standardizing the analysis of physical activity in patients with COPD following a pulmonary rehabilitation program. Chest 2014;146(2):318-27.

Sedentary Behaviour Research N. Letter to the editor: standardized use of the terms "sedentary" and "sedentary behaviours". Appl Physiol Nutr Metab 2012;37(3):540-2.

Ramon MA, Ter Riet G, Carsin AE, Gimeno-Santos E, Agustí A, Antó JM, et al. The dyspnoea-inactivity vicious circle in COPD: development and external validation of a conceptual model. Eur Respir J 2018;15;52(3). doi: 10.1183/13993003.00079-2018.

Gouzi F, Préfaut C, Abdellaoui A, Vuillemin A, Molinari N, Ninot G, et al. Evidence of an early physical activity reduction in chronic obstructive pulmonary disease. Arch Phys Med Rehabil 2011;92(10):1611-1617

Maltais F, Decramer M, Casaburi R, Barreiro E, Burelle Y, Debigare R, et al. An official American Thoracic Society/European Respiratory Society statement: update on limb muscle dysfunction in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2014;189(9):e15-62.

Fernandes AC, Bezerra OM. Nutrition therapy for chronic obstructive pulmonary disease and related nutritional complications. J Bras Pneumol 2006;32(5):461-471.

Tremblay MS, Colley RC, Saunders TJ, Healy GN, Owen N. Physiological and health implications of a sedentary lifestyle. Appl Physiol Nutr Metab 2010;35(6):725-740.

Rodrigues A, Camillo CA, Furlanetto KC, Paes T, Morita AA, Spositon T. Cluster analysis identifying patients with COPD at higt risk of 2-year all-cause mortality. Chron Respir Dis 2019;16:1479972318809452.

Casanova C, Celli BR, Barria P, Casas A, Cote C, de Torres JP, et al. The 6-min walk distance in healthy subjects: reference standards from seven countries. Eur Respir J 2011;37(1):150-6.

Downloads

Publicado

2019-12-20

Como Citar

1.
Silva TS da, Rodrigues A, Micheleti JF, Hernandes NA, Pitta F, Furlanetto KC. Mortality in COPD: Comparison of Different Predictors in Patients Seeking a Pulmonary Rehabilitation Program. J. Health Sci. [Internet]. 20º de dezembro de 2019 [citado 26º de abril de 2024];21(4):390-6. Disponível em: https://journalhealthscience.pgsscogna.com.br/JHealthSci/article/view/6610

Edição

Seção

Artigos